Metabolic Care Today
Advertisement
Personalized obesity care combining medication and lifestyle delivers better, longer-lasting weight loss and health outcomes.
When diet and exercise wave the white flag, real medicine rolls in like the superhero with a prescription pad!
Dr. Alex McDonald and Dr. Regina Regasa explore obesity’s health impact and a multifaceted approach for effective care.
Lifestyle and metformin interventions cut diabetes risk for 21 years in adults with prediabetes, DPP study shows.
Black youth with dysglycemia show reduced insulin clearance, possibly contributing to β-cell dysfunction and ...
Tirzepatide linked to reduced muscle fat infiltration and volume in type 2 diabetes, per SURPASS-3 MRI substudy findings.
Real-world weight loss with semaglutide or tirzepatide is lower due to early discontinuation and low maintenance dosing.
Chronic hyperglycemia in pediatric type 1 diabetes may impair white matter development; brain changes persist into puberty.
Nearly half of U.S. patients discontinued semaglutide within 5 months, with cost a key barrier to continued use.
How many medications are FDA-approved for the long-term use of treating obesity?
Habits collapsed, health's calling 'Mayday'! The doc soars in ... time to dose the FDA way!
Obesity care must be evidence-based and patient-centered, says Dr. Auriemma in this call for science-driven treatment.
Obesity is a chronic, complex disease driven by biology, not just behavior—effective care requires empathy and support.
A new study investigated the effects of physical training on aging in the skeletal muscle of people with obesity.
Researchers report a sharp increase in extreme forms of obesity in the U.S.
Trachtenberg's sudden death highlights the dangers of diabetes, including chronic and transplant-related complications.
The systematic review considered 144 studies that involved diabetes or obesity.
The guideline supports "value- and preference-sensitive decision-making" for children with obesity and their families.
The two predictive models are called the Diabetes Remission Index and the Weight Loss-Adjusted Diabetes Remission Index.
Estimates show that 2.2 million new cases of T2D and 1.2 million new cases of CVD are associated with sugary beverages.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.